| Theme | New developments in capsule/balloon-assisted endoscopy | |
|---|---|---|
| Title | Feasibility of evaluating severity of mucosal inflammation in ulcerative colitis patients with second generation colon capsule endoscope | |
| Publish Date | 2013/12 | |
| Author | Naoki Hosoe | Center for Diagnostic and Therapeutic Endoscopy, School of Medicine, Keio University |
| Author | Katsuyoshi Matsuoka | Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Keio University |
| Author | Makoto Naganuma | Center for Diagnostic and Therapeutic Endoscopy, School of Medicine, Keio University |
| Author | Masaru Nakano | Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital |
| Author | Tadakazu Hisamatsu | Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Keio University |
| Author | Nagamu Inoue | Center for Preventive Medicine, School of Medicine, Keio University |
| Author | Takanori Kanai | Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Keio University |
| Author | Hiroshi Serizawa | Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital |
| Author | Toshifumi Hibi | Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital |
| Author | Haruhiko Ogata | Center for Diagnostic and Therapeutic Endoscopy, School of Medicine, Keio University |
| [ Summary ] | The aim of this study was to assess the feasibility of evaluating the severity of mucosal inflammation in patients with ulcerative colitis (UC) using a second generation colon capsule endoscope (CCE-2). The completion rate for the CCE-2 procedure and the cleansing effectiveness of bowel preparations were seen to be insufficient. However, Matts endoscopic scores determined with CCE-2 showed a strong correlation with scores obtained with conventional colonoscopy. Though modifications of bowel preparations is needed, CCE-2 may be feasible for assessment of the severity of mucosal inflammation in patients with UC. | |